Agency for Medicinal Products and Medical Devices of Croatia

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. University Medical Center Groningen荷兰4
2. Medicines and Healthcare products Regulatory Agency英国4
3. Agencia Española de Medicamentos y Productos Sanitarios西班牙4
4. Italian Medicines Agency意大利4
5. Netherlands Pharmacovigilance Centre Lareb荷兰4
6. Medicines Evaluation Board荷兰2
7. Uppsala Monitoring Centre瑞典2
8. University of Verona意大利2

按月发文

逐年被引

最新文献

1. 1
   Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First DoseDrug Safety202328
2. 2
   Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UKDrug Safety202114
3. 3
   Correction to: Safety Communication Tools and Healthcare Professionals’ Awareness of Specific Drug Safety Issues in Europe: A Survey StudyDrug Safety20201
4. 4
   Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint ActionDrug Safety201832
5. 5
   Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional StudyDrug Safety201833
6. 6
   Safety Communication Tools and Healthcare Professionals’ Awareness of Specific Drug Safety Issues in Europe: A Survey StudyDrug Safety201826
7. 7
   Communication on Safety of Medicines in Europe: Current Practices and General Practitioners’ Awareness and PreferencesDrug Safety201742
8. 8
   A retrospective review of paediatric adverse drug reactions reported in Lombardy and Croatia from 2005 to 2013Expert Opinion on Drug Safety20161
9. 9
   Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?Drug Safety201674
10. 10
    National consumption of opioid and nonopioid analgesics in Croatia: 2007–2013Therapeutics and Clinical Risk Management201516

高被引文献

1. 1
   Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?Drug Safety201674
2. 2
   Communication on Safety of Medicines in Europe: Current Practices and General Practitioners’ Awareness and PreferencesDrug Safety201742
3. 3
   Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional StudyDrug Safety201833
4. 4
   Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint ActionDrug Safety201832
5. 5
   Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First DoseDrug Safety202328
6. 6
   Safety Communication Tools and Healthcare Professionals’ Awareness of Specific Drug Safety Issues in Europe: A Survey StudyDrug Safety201826
7. 7
   National consumption of opioid and nonopioid analgesics in Croatia: 2007–2013Therapeutics and Clinical Risk Management201516
8. 8
   Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UKDrug Safety202114
9. 9
   A retrospective review of paediatric adverse drug reactions reported in Lombardy and Croatia from 2005 to 2013Expert Opinion on Drug Safety20161
10. 10
    Correction to: Safety Communication Tools and Healthcare Professionals’ Awareness of Specific Drug Safety Issues in Europe: A Survey StudyDrug Safety20201

主要发表期刊

研究主题